Analyst Price Target is $30.00
▲ +757.14% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Aspira Women's Health in the last 3 months. The average price target is $30.00, with a high forecast of $30.00 and a low forecast of $30.00. The average price target represents a 757.14% upside from the last price of $3.50.
Current Consensus is
The current consensus among 2 contributing investment analysts is to hold stock in Aspira Women's Health. This rating has held steady since March 2022, when it changed from a Buy consensus rating.
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.